Vista Pharma.

{
  "main_header": {
    "sid": 384463,
    "name": "Vista Pharma.",
    "stock_name": "Vista Pharma.",
    "full_name": "Vista Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/vista-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "7.51",
    "chg": -0.6,
    "chgp": "-7.4%",
    "dir": -1,
    "prev_price": "8.11",
    "mcapval": "48.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524711,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE427C01021",
    "curr_date": "Feb 06",
    "curr_time": "",
    "bse_nse_vol": "11.21 k",
    "exc_status": "Active",
    "traded_date": "Feb 06, 2026",
    "traded_date_str": "2026 02 06",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/vista-pharma-384463-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Vista Pharmaceuticals Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/vista-pharmaceuticals-ltd-is-rated-strong-sell-3824110",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/VistaPharmaceut_mojoScore_3824110.png",
        "date": "2026-02-06 10:10:27",
        "description": "Vista Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 18 July 2024. However, the analysis and financial metrics discussed here reflect the company’s current position as of 06 February 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Vista Pharmaceuticals Ltd Stock Hits 52-Week Low at Rs.6.57",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/vista-pharmaceuticals-ltd-stock-hits-52-week-low-at-rs657-3814289",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/VistaPharmaceut_priceRelatedfactors_3814289.png",
        "date": "2026-02-01 10:42:12",
        "description": "Vista Pharmaceuticals Ltd has reached a new 52-week low price of Rs.6.57, marking a significant decline amid ongoing financial pressures and subdued market performance within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Vista Pharmaceuticals Ltd Falls to 52-Week Low of Rs.7",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/vista-pharmaceuticals-ltd-falls-to-52-week-low-of-rs7-3806144",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/VistaPharmaceut_priceRelatedfactors_3806144.png",
        "date": "2026-01-27 13:10:46",
        "description": "Vista Pharmaceuticals Ltd’s stock touched a new 52-week low of Rs.7 today, marking a significant decline amid persistent downward momentum. The stock has underperformed its sector and broader market indices, reflecting ongoing financial pressures and subdued performance metrics."
      },
      {
        "title": "Vista Pharmaceuticals Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/vista-pharmaceuticals-ltd-is-rated-strong-sell-3804603",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/VistaPharmaceut_mojoScore_3804603.png",
        "date": "2026-01-26 10:10:17",
        "description": "Vista Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 18 July 2024, but the analysis below reflects the stock’s current position as of 26 January 2026, incorporating the latest fundamentals, returns, and financial metrics available today."
      },
      {
        "title": "Vista Pharmaceuticals Ltd Falls to 52-Week Low of Rs.7.61",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/vista-pharmaceuticals-ltd-falls-to-52-week-low-of-rs761-3796053",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/VistaPharmaceut_priceRelatedfactors_3796053.png",
        "date": "2026-01-20 10:18:19",
        "description": "Vista Pharmaceuticals Ltd touched a new 52-week low of Rs.7.61 today, marking a significant decline in its share price amid a broader market downturn and persistent company-specific headwinds."
      },
      {
        "title": "Why is Vista Pharmaceuticals Ltd falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-vista-pharmaceuticals-ltd-fallingrising-3779250",
        "imagepath": "",
        "date": "2026-01-03 01:39:22",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Context</strong></p>\n<p>Vista Pharmaceuticals Ltd’s share price has fallen by ₹0.16 on 02-Jan, marking a near 2% drop in a single session. This decline is part of a wider negative trend, with the stock losing 6.76% over the past week, in stark contrast to the Sensex’s modest gain of 0.85% during the same period. Over the last month, the stock has declined by 2.79%, while the benchmark index has advanced by 0.73%. Even year-to-date, Vista Pharma’s shares have slipped 1.72%, whereas the Sensex has recorded a 0.64% increase. These figures highlight the stock’s consistent underperformance against the broader market.</p>\n<p><strong>Long-Term Underperformance Compared to Benchmarks</strong></p>\n<p>Examining the longer-term performance reveals a more concerning pict..."
      },
      {
        "title": "Vista Pharmaceuticals Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/vista-pharmaceuticals-ltd-is-rated-strong-sell-3769687",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/VistaPharmaceut_mojoScore_3769687.png",
        "date": "2025-12-25 15:12:53",
        "description": "Vista Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 18 Jul 2024, reflecting a significant reassessment of the stock’s outlook. However, the analysis and financial data presented here are based on the company’s current position as of 25 December 2025, providing investors with the latest insights into its performance and prospects."
      },
      {
        "title": "Vista Pharma. Sees Revision in Market Assessment Amid Challenging Financial Trends",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/vista-pharma-downgraded-to-strong-sell-amid-deteriorating-fundamentals-and-bearish-technicals-3750096",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/VistaPharma_mojoScore_3750096.png",
        "date": "2025-12-07 10:10:21",
        "description": "Vista Pharma., a microcap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting ongoing challenges in its financial and operational performance. The recent assessment highlights concerns across multiple parameters including quality, valuation, financial trends, and technical outlook, underscoring the stock's current position within a difficult market environment."
      },
      {
        "title": "Why is Vista Pharma. falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-vista-pharma-fallingrising-3715985",
        "imagepath": "",
        "date": "2025-11-19 21:49:42",
        "description": "As of 19-Nov, Vista Pharmaceuticals Ltd is experiencing a price increase, currently at Rs 9.18, which represents a rise of 1.53 or 20.0%. Today, the stock has outperformed its sector by 19.93% and has shown a trend reversal after two consecutive days of decline. It opened with a significant gain of 9.54% and reached an intraday high of Rs 9.18. However, despite this positive movement, the stock has been trading lower than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Additionally, there has been a notable decrease in investor participation, with delivery volume falling by 25.71% compared to the 5-day average, indicating a potential concern regarding sustained interest in the stock.\n\nIn the broader market context, Vista Pharmaceuticals has underperformed compared to the Sensex over various periods, including a 3-year return of +19.22% against the Sensex's +38.15%. In the short term, the st..."
      }
    ],
    "total": 5704,
    "sid": "384463",
    "stock_news_url": "https://www.marketsmojo.com/news/vista-pharmaceuticals-384463"
  },
  "announcements": [
    {
      "caption": "Update on board meeting",
      "datetime": "05-Feb-2026",
      "details": "The Board Meeting to be held on 23/02/2026 has been revised to 13/02/2026 The Board Meeting to be held on 23/02/2026 has been revised to 13/02/2026",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for 1. Unaudited Financial Results For The Quarter And Nine Months Ended 31.12.2025. 2. Limited Review Report Quarter And Nine Months 31.12.2025. 3. Any Other Business With The Permission Of The Chair.",
      "datetime": "05-Feb-2026",
      "details": "Vista Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/02/2026 inter alia to consider and approve 1. Unaudited financial results for the quarter and nine months ended 31.12.2025. 2. Limited Review Report quarter and nine months 31.12.2025. 3. Any other business with the permission of the Chair.",
      "source": "BSE"
    },
    {
      "caption": "Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Joint Venture Partnership Between Pleiades Therapeutics And Vista Pharmaceuticals Ltd",
      "datetime": "03-Feb-2026",
      "details": "Disclosure",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "13 Feb 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Vista Pharmaceuticals Ltd is Rated Strong Sell

2026-02-06 10:10:27

Vista Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 18 July 2024. However, the analysis and financial metrics discussed here reflect the company’s current position as of 06 February 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Vista Pharmaceuticals Ltd Stock Hits 52-Week Low at Rs.6.57

2026-02-01 10:42:12

Vista Pharmaceuticals Ltd has reached a new 52-week low price of Rs.6.57, marking a significant decline amid ongoing financial pressures and subdued market performance within the Pharmaceuticals & Biotechnology sector.

Read full news article

Vista Pharmaceuticals Ltd Falls to 52-Week Low of Rs.7

2026-01-27 13:10:46

Vista Pharmaceuticals Ltd’s stock touched a new 52-week low of Rs.7 today, marking a significant decline amid persistent downward momentum. The stock has underperformed its sector and broader market indices, reflecting ongoing financial pressures and subdued performance metrics.

Read full news article

Vista Pharmaceuticals Ltd is Rated Strong Sell

2026-01-26 10:10:17

Vista Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 18 July 2024, but the analysis below reflects the stock’s current position as of 26 January 2026, incorporating the latest fundamentals, returns, and financial metrics available today.

Read full news article

Vista Pharmaceuticals Ltd Falls to 52-Week Low of Rs.7.61

2026-01-20 10:18:19

Vista Pharmaceuticals Ltd touched a new 52-week low of Rs.7.61 today, marking a significant decline in its share price amid a broader market downturn and persistent company-specific headwinds.

Read full news article

Why is Vista Pharmaceuticals Ltd falling/rising?

2026-01-03 01:39:22

Recent Price Movement and Market Context

Vista Pharmaceuticals Ltd’s share price has fallen by ₹0.16 on 02-Jan, marking a near 2% drop in a single session. This decline is part of a wider negative trend, with the stock losing 6.76% over the past week, in stark contrast to the Sensex’s modest gain of 0.85% during the same period. Over the last month, the stock has declined by 2.79%, while the benchmark index has advanced by 0.73%. Even year-to-date, Vista Pharma’s shares have slipped 1.72%, whereas the Sensex has recorded a 0.64% increase. These figures highlight the stock’s consistent underperformance against the broader market.

Long-Term Underperformance Compared to Benchmarks

Examining the longer-term performance reveals a more concerning pict...

Read full news article

Vista Pharmaceuticals Ltd is Rated Strong Sell

2025-12-25 15:12:53

Vista Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 18 Jul 2024, reflecting a significant reassessment of the stock’s outlook. However, the analysis and financial data presented here are based on the company’s current position as of 25 December 2025, providing investors with the latest insights into its performance and prospects.

Read full news article

Vista Pharma. Sees Revision in Market Assessment Amid Challenging Financial Trends

2025-12-07 10:10:21

Vista Pharma., a microcap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting ongoing challenges in its financial and operational performance. The recent assessment highlights concerns across multiple parameters including quality, valuation, financial trends, and technical outlook, underscoring the stock's current position within a difficult market environment.

Read full news article

Why is Vista Pharma. falling/rising?

2025-11-19 21:49:42

As of 19-Nov, Vista Pharmaceuticals Ltd is experiencing a price increase, currently at Rs 9.18, which represents a rise of 1.53 or 20.0%. Today, the stock has outperformed its sector by 19.93% and has shown a trend reversal after two consecutive days of decline. It opened with a significant gain of 9.54% and reached an intraday high of Rs 9.18. However, despite this positive movement, the stock has been trading lower than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Additionally, there has been a notable decrease in investor participation, with delivery volume falling by 25.71% compared to the 5-day average, indicating a potential concern regarding sustained interest in the stock. In the broader market context, Vista Pharmaceuticals has underperformed compared to the Sensex over various periods, including a 3-year return of +19.22% against the Sensex's +38.15%. In the short term, the st...

Read full news article

View All News